Yüklüyor......

DOTA-ZOL: A Promising Tool in Diagnosis and Palliative Therapy of Bone Metastasis—Challenges and Critical Points in Implementation into Clinical Routine

The novel compound 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-ZOL (DOTA-conjugated zoledronic acid) is a promising candidate for the diagnosis and therapy of bone metastasis. The combination of the published methodology for this bisphosphonate with pharmaceutical and regulatory...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Molecules
Asıl Yazarlar: Meisenheimer, Michael, Kürpig, Stefan, Essler, Markus, Eppard, Elisabeth
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2020
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7412164/
https://ncbi.nlm.nih.gov/pubmed/32629930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules25132988
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!